Literature DB >> 11586486

Polymorphisms 1704G/T and 2184A/G in the RAGE gene are associated with antioxidant status.

K Kanková1, I Márová, J Záhejský, J Muzík, A Stejskalová, V Znojil, J Vácha.   

Abstract

The formation of advanced glycation end products (AGEs) and oxidative stress are supposed to play an important role in the development of diabetic late complications. AGEs can bind to several binding sites including receptor of advanced glycation end products (RAGE). AGE-RAGE interaction results in free radical generation. The aim of the present study was to investigate the impact of previously described polymorphisms in the RAGE gene (G82S, 1704G/T, 2184A/G, and 2245G/A) on the glycoxidation status in non-insulin-dependent diabetes mellitus (NIDDM). A total of 371 unrelated caucasian subjects were enrolled in the study. The NIDDM group consisted of 202 subjects, and the presence of late diabetic complications in 5 particular localizations was expressed as an index (I(compl)). The nondiabetic group included 169 subjects. Glycated hemoglobin (HbA(1c)), glycated stratum corneum proteins (Amadori, AGE), total carotenoids, alpha- and beta -carotene, gamma-tocopherol, lutein, lycopene, and alpha-tocopherol were measured in each subject. Statistically significant differences in allele frequencies between the NIDDM and the nondiabetic groups were observed for the G82S and 2245G/A polymorphisms (P =.047 and .032, respectively). HbA(1c), Amadori, and AGE did not reveal any significant association with any of the polymorphisms analyzed. However, significant differences between subjects bearing "wild-type majority" genotypes 1704GG+2184AA and subjects with "mutated" genotypes were found for total carotenoids (P =.001), alpha-carotene (P =.046), beta-carotene (P =.028), lutein (P =.001), lycopene (P =.006), and alpha-tocopherol (P =.047). I(compl) significantly correlated with the plasma levels of all antioxidants (all P <.01), while no correlation of I(compl) with glycation variables was observed. The newly identified intron polymorphisms in the RAGE gene were proved to be associated with the antioxidant status in NIDDM subjects. The extent of diabetic vascular disease is related to the plasma levels of antioxidants. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11586486     DOI: 10.1053/meta.2001.26757

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

1.  Expression of the receptor for advanced glycation end-products and frequency of polymorphism in lung cancer.

Authors:  Hongmei Wang; Yongchun Li; Wencheng Yu; Liqing Ma; Xia Ji; Wei Xiao
Journal:  Oncol Lett       Date:  2015-05-12       Impact factor: 2.967

2.  Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population.

Authors:  H M Zhang; L L Chen; L Wang; Y F Liao; Z H Wu; F Ye; S Xu; L L Yi
Journal:  J Endocrinol Invest       Date:  2009-03       Impact factor: 4.256

3.  Higher serum soluble receptor for advanced glycation end product levels and lower prevalence of metabolic syndrome among Japanese adult men: a cross-sectional study.

Authors:  Haruki Momma; Kaijun Niu; Yoritoshi Kobayashi; Cong Huang; Masahiko Chujo; Atsushi Otomo; Hiroko Tadaura; Toshio Miyata; Ryoichi Nagatomi
Journal:  Diabetol Metab Syndr       Date:  2014-03-06       Impact factor: 3.320

4.  Soluble receptor for advanced glycation end-product (sRAGE)/pentosidine ratio: a potential risk factor determinant for type 2 diabetic retinopathy.

Authors:  Zhi Xiang Ng; Kek Heng Chua; Tajunisah Iqbal; Umah Rani Kuppusamy
Journal:  Int J Mol Sci       Date:  2013-04-03       Impact factor: 5.923

Review 5.  Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis.

Authors:  Christian Bopp; Angelika Bierhaus; Stefan Hofer; Axel Bouchon; Peter P Nawroth; Eike Martin; Markus A Weigand
Journal:  Crit Care       Date:  2008-01-09       Impact factor: 9.097

6.  Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population.

Authors:  Li Yang; Qunhong Wu; Yuan Li; Xiaohong Fan; Yanhua Hao; Hong Sun; Yu Cui; Liyuan Han
Journal:  J Diabetes Res       Date:  2013-11-04       Impact factor: 4.011

7.  Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease.

Authors:  Foo Nian Wong; Kek Heng Chua; Umah Rani Kuppusamy; Chew Ming Wong; Soo Kun Lim; Jin Ai Mary Anne Tan
Journal:  PeerJ       Date:  2016-04-18       Impact factor: 2.984

Review 8.  Update on genetics and diabetic retinopathy.

Authors:  Blake M Hampton; Stephen G Schwartz; Milam A Brantley; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2015-11-23

9.  Association of 2184AG Polymorphism in the RAGE Gene with Diabetic Nephropathy in Chinese Patients with Type 2 Diabetes.

Authors:  Wei Cai; Jian Li; Ji-Xiong Xu; Ying Liu; Wei Zhang; Jun-Ren Xiao; Ling-Yan Zhu; Jian-Ying Liu
Journal:  J Diabetes Res       Date:  2015-12-03       Impact factor: 4.011

10.  Polymorphism 2184A/G in the AGER gene is not associated with diabetic retinopathy in Han Chinese patients with type 2 diabetes.

Authors:  Jian Li; Wei Cai; Wei Zhang; Wei-Feng Zhu; Ying Liu; Li-Xia Yue; Ling-Yan Zhu; Jun-Ren Xiao; Jian-Ying Liu; Ji-Xiong Xu
Journal:  J Int Med Res       Date:  2016-03-31       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.